LabKey Server: An open source platform for scientific data integration, analysis and collaboration by Nelson, Elizabeth K et al.
SOFTWARE Open Access
LabKey Server: An open source platform for
scientific data integration, analysis and
collaboration
Elizabeth K Nelson
1*, Britt Piehler
1, Josh Eckels
1, Adam Rauch
1, Matthew Bellew
1, Peter Hussey
1, Sarah Ramsay
2,
Cory Nathe
2, Karl Lum
1, Kevin Krouse
1, David Stearns
1, Brian Connolly
1, Tom Skillman
2, Mark Igra
1
Abstract
Background: Broad-based collaborations are becoming increasingly common among disease researchers. For
example, the Global HIV Enterprise has united cross-disciplinary consortia to speed progress towards HIV vaccines
through coordinated research across the boundaries of institutions, continents and specialties. New, end-to-end
software tools for data and specimen management are necessary to achieve the ambitious goals of such alliances.
These tools must enable researchers to organize and integrate heterogeneous data early in the discovery process,
standardize processes, gain new insights into pooled data and collaborate securely.
Results: To meet these needs, we enhanced the LabKey Server platform, formerly known as CPAS. This freely available,
open source software is maintained by professional engineers who use commercially proven practices for software
development and maintenance. Recent enhancements support: (i) Submitting specimens requests across collaborating
organizations (ii) Graphically defining new experimental data types, metadata and wizards for data collection (iii)
Transitioning experimental results from a multiplicity of spreadsheets to custom tables in a shared database (iv) Securely
organizing, integrating, analyzing, visualizing and sharing diverse data types, from clinical records to specimens to complex
assays (v) Interacting dynamically with external data sources (vi) Tracking study participants and cohorts over time (vii)
Developing custom interfaces using client libraries (viii) Authoring custom visualizations in a built-in R scripting environment.
Diverse research organizations have adopted and adapted LabKey Server, including consortia within the Global HIV
Enterprise. Atlas is an installation of LabKey Server that has been tailored to serve these consortia. It is in
production use and demonstrates the core capabilities of LabKey Server. Atlas now has over 2,800 active user
accounts originating from approximately 36 countries and 350 organizations. It tracks roughly 27,000 assay runs,
860,000 specimen vials and 1,300,000 vial transfers.
Conclusions: Sharing data, analysis tools and infrastructure can speed the efforts of large research consortia by
enhancing efficiency and enabling new insights. The Atlas installation of LabKey Server demonstrates the utility of
the LabKey platform for collaborative research. Stable, supported builds of LabKey Server are freely available for
download at http://www.labkey.org. Documentation and source code are available under the Apache License 2.0.
Background
To gain insight into complex, variable diseases like HIV,
researchers need to bring together many different types
of information from varied sources at early stages of
research. Software systems that provide secure data inte-
gration, analysis and sharing can facilitate collaborative
efforts against such diseases; however, existing software
has significant limitations. Existing software systems
typically do not span the full flow of data through an
organization, require commercial licenses, focus on lim-
ited data types, provide limited extensibility, or cannot
easily be used beyond the organizations that designed
them. We developed LabKey Server as an end-to-end,
“biology-aware” data integration platform that can be
customized to meet the needs of diverse research orga-
nizations. The source code isf r e e l ya v a i l a b l eu n d e rt h e
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been proven in heavy production use and is maintained
by a professional development team.
One of the largest installations of LabKey Server is
called Atlas. It is managed by the Statistical Center for
HIV/AIDS Research and Prevention (SCHARP) at the
Fred Hutchinson Cancer Research Center. This installa-
tion illustrates the core capabilities of LabKey Server
and demonstrates how these capabilities have helped a
large organization accelerate and enhance research
efforts.
The vast majority of LabKey Server features developed
for Atlas are built into the LabKey Server platform and
available as part of the open source project. Certain cus-
tomizations of the Atlas installation are closely tailored
to particular projects or studies, so they are not part of
the open source project. They are only mentioned here
as illustrations of extensibility, and they are noted as
such.
Atlas has grown out of SCHARP’s efforts to meet the
needs of several consortia within the Global HIV Vac-
cine Enterprise (the Enterprise) [2]. The Enterprise is a
virtual coalition of researchers that aims to accelerate
progress towards one of the most challenging problems
in medicine, the development of HIV vaccines [2-6].
Following the example of the Human Genome Project
[7], the Enterprise aims to set common goals, standar-
dize processes and share data and techniques as soon as
they are developed. Just like the Human Genome Pro-
ject, this endeavour requires a massive data integration
effort. Unlike the Human Genome Project, but like
other large-scale, collaborative efforts against intractable
diseases, the Enterprise must integrate a large number
of data types. These include results from diverse assays,
clinical records and sample information. Though Atlas
is not a formal project of the Enterprise itself and has
no official endorsement, it is used by a variety of con-
sortia within the Enterprise to accelerate scientific
discovery.
Requirements
Uniting distributed efforts to investigate the biology and
the treatment of an evolving disease poses challenges for
data management tools. To gain insight into viral/host
dynamics, researchers need to bring together diverse
types of data (e.g., viral loads, specimen records and
clinical notes) at all stages of research, even when the
data originate from multiple labs and clinics across the
globe. Researchers need to be able to see many different
data types simultaneously to investigate study partici-
pants who have exceptional immune responses, such as
elite controllers or rapid progressors. They require the
agility to extract lessons from failed trials and move
investigations quickly in new directions, or to swiftly
scale up their successes. Researchers require tools to
support the development, standardization and dissemi-
nation of new, improved assay protocols and workflows
across organizations. Furthermore, they need to be able
to quickly apply new analysis techniques to existing
datasets without the assistance of computer program-
mers. Tools must be capable of handling the quantity
and complexity of data generated by high-throughput
technologies. As a team, they need to improve the qual-
ity, reproducibility and com p a r a b i l i t yo fd a t at h r o u g h
standardization of lab measurements and procedures.
Globally distributed teams need to rapidly, securely
exchange information and specimens, ideally through a
single, unified interface.
Alternatives
Although existing software tools [8-28] could meet some
of the requirements of the Atlas project, none meet all of
them in the form of a comprehensive, end-to-end plat-
form available as open source. Some tools have experi-
enced only limited use. A few broad, commercial systems
have recently been introduced (e.g., Microsoft Amalga
Life Sciences [29], Genologics [30], Genedata [31] and
Axiope eCAT [32,33]); however, they lack the transpar-
ency of open source solutions, so they are not reviewed
here. Existing open source tools typically lack key fea-
tures, such as role-based permissions, document sharing,
easy extensibility, specimen requests, observational study
management, full-text search, dynamic interaction with
external data sources, integration with analysis tools like
R, and support for describing arbitrary, complex experi-
mental data types. Table 1 provides an overview of the
feature tradeoffs between representative platforms.
To our knowledge, no other open source tool provides
support for both web-based specimen requisitions and
integration of specimen data with complex experimental
results. For example, PASSIM [8] (and derivatives SLIMS
[34] and SIMBioMS [9]), caTissue [35], ePIMS [36] and
BASE [10]) all provide sample provenance tracking, but
none of these allow for web-based sample requests. eOn-
coLIMS [37] supports equipment requests and GNomEx
[38] supports experimental work requests, but neither
one supports specimen transfers. i2b2 [11] has some
form of a sample request module (i2b2 - Crimson) under
construction, but it has not yet been released. BSI [39]
provides sample requisition support but does not provide
for integration of sample and experimental data. CAISIS
[12,13] is exceptional in providing both specimen
requests and deep support for data integration; however,
it only supports simple test results entered through
online forms, not complex experimental data types.
Many tools allow users to describe and collect custom
metadata for experiments (e.g., Addama [14], BASE [10],
i L A P[ 1 5 ] ,S I M B i o M S[ 9 ] ,I SA [16]). Several tools (e.g.,
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customizable or domain-standardized wizards for col-
lecting metadata for experiments during data import.
Unfortunately, all of these tools store only metadata in
their databases, not results. Keeping results out of a
database makes perfect sense for exceptionally large
result sets (e.g., microarray results); however, database
import is often desirable for smaller datasets because it
allows SQL-based querying. Open source software does
not typically provide graphical, run-time tools for
describing schemas for arbitrary, complex assay results
and then performing advanced queries over both data
and metadata.
Furthermore, no other open source platform known to
us provides graphical facilities for defining a broad range of
customizable, scientifically-relevant properties for any col-
umn of data (such as missing value indicators, regular
expression validators, default values and lookup relation-
ships). CAISIS [12] allows the definition of a few of these
properties (default values, defined vocabularies and collec-
tion requirements) for simple lab and clinical results; how-
ever, it provides no support for complex experimental data.
Many of the widely known frameworks for data integra-
tion (e.g., BioMart [40]) are tailored primarily towards
working with published data, after results have reached
“finished” form, not for integrating evolving data types
during the research process [14]. Even among tools tar-
geted towards research data, such as electronic lab note-
books, alteration or addition of data types typically
requires database alterations [17]. Tools designed for inte-
grating raw research data often work only with specific
data formats (e.g., SBEAMS [18], caIntegrator [41] and
GenePattern [42]) or support the introduction or exten-
sion of data types only when the system is not running
(e.g., Intermine [19]). Even when tools provide flexibility in
defining relationships between tables (e.g., Intermine [19]),
they typically lack graphical tools for doing so. Such
approaches are practical when data types are reasonably
static and standard, but not when these types need to
evolve quickly, without developer support, as research
advances [14].
Many data integration tools (e.g., Intermine [19], Bio-
Mart [40] and Atlas (unrelated to SCHARP’sA t l a s )
[20]) lack dynamic access to external data sources and
require aggregation of all data into a central warehouse.
Updates can be challenging when external data sources
change [43,44]. Fully decentralized approaches (such as
those used by BioMOBY [45]) are not easily amendable
to consistent quality control [46].
Open source clinical data management software tools
(e.g., CAISIS [12,13], OpenClinica [47] and openCDMS
[48]) typically lack features necessary for managing both
study data and highly dimensional experimental data.
For example, they typically lack the ability to collect
complex assay data in batches of runs. When open
source systems do facilitate integration of both study
and experimental data types, they typically support only
limited data types or allow only narrow queries. For
example, SIMBioMS [9] understands relationships
between participants, specimens and experimental
results; however, it lacks extensible types, recognizes
only particular data file formats, and allows users to fil-
ter only on metadata, not to fully query experimental
results. i2b2 [11] provides more of the querying capabil-
ities desired by SCHARP. However, it requires that all
imported data map to a set of fixed schemas, lacks data
type extensibility and does not support experimental
data management.
Table 1 Feature tradeoffs between platforms
Platforms
Features CAISIS i2b2 SIMBioMS ISA Intermine LabKey
Server
Specimen requests + - - - - +
Role-based permissions + + - - + +
Built-in understanding of clinical study entities (e.g., participants and visits) + + + - - +
Management of high-throughput assay results - - + + + +
Wizards for collecting custom metadata for experiments + + + + - +
Result schemas (not just metadata) customizable through graphical interface + - - - - +
Broad range of customizable, scientifically-relevant properties for every column of data - - - - - +
Graphical tools for setting up lookups between tables + - - - - +
Complex queries on experimental results, not just metadata + + - - + +
Libraries to support programmatic data manipulation and user interface creation from
external code
-+ - - + +
Built-in user interface for scripting in R - - - - - +
Dynamic interaction with external data sources - - - - - +
This table compares LabKey Server with a representative sample of open source platforms for data integration. The focus of these platforms ranges from clinical
research to high-throughput experiments. Documentation for many platforms is incomplete, so we can provide only a reasonable inference of feature availability.
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[20]) furnish client libraries, but few (e.g., GMOD-DBSF
[21] and Intermine [19]) provide APIs both for custo-
mizing interfaces and for querying data. Many tools that
focus primarily on biological data integration (e.g., Bio-
Mart [40], GMOD-DBSF [21], Intermine [19], iLAP [15]
and Addama [14]) supply some form of integration with
open source analysis tools; however, none known to us
provides a built-in, graphical R interface.
The Atlas Installation of LabKey Server
The SCHARP team found existing software alternatives
to be insufficient, so team members collaborated with
the LabKey Software team to enhance the LabKey Ser-
ver platform and to establish Atlas. Atlas is an installa-
tion of LabKey Server customized with interfaces
specific to Enterprise studies. Atlas does not aim to
meet all needs of all researchers within the Enterprise;
instead, its core mission is to tie together many different
lab systems and data sources, as shown in Figure 1.
Significance of Latest Enhancements
Recent improvements to LabKey Server have empha-
sized scenarios that support Atlas’sr o l ea sa n
information hub. These enhancements are significant in
providing:
(1) Specimen requests and tracking. Users can
track specimen records, execute web-based requests
for specimens and integrate specimen information
with clinical data and complex experimental results.
No other platform known to us supports all of these
scenarios.
(2) Management of experimental data types that
a r ei n v e n t e do rm o d i f i e da sp r o j e c t se v o l v e .L a b -
Key Server’s graphical assay design tools are novel in
the way they allow scientists to quickly describe and
manage arbitrary assay data types, plus extend built-
in assay types. Users can graphically associate a
broad range of scientifically-relevant properties (e.g.,
regular expression validators and standardized out-
of-range markers) with each column of assay data
and metadata. These properties can facilitate quality
control, visualization and analysis.
(3) Integration, analysis and visualization of
diverse data sources. The platform’s tools for creat-
ing custom, integrated views of data are exceptional
in spanning not just built-in data types and sources,
but also user-extended data types. Furthermore, Lab-
Key Server is the only open source system known to
us that allows users to integrate clinical data, speci-
men records and complex experimental results by
leveraging: (i) basic relationships between study enti-
ties (e.g., participants, cohorts, visits and specimens)
(ii) SQL-based queries and (iii) graphical view-build-
ing tools. The system is also noteworthy for provid-
ing dynamic access to external data sources.
(4) Extensibility. It is unusual for a scientific data
management system to provide backwards-compati-
ble, well-documented client libraries that enable
developers to both interact with stored data and to
construct custom interfaces. It is also unusual for a
system to provide such rich client libraries that
developers do not need to become well-versed in the
system’s object model to quickly develop rich con-
tent. Lastly, LabKey Server’s built-in, web-based
interface for writing and deploying custom R scripts
is also exceptional among data integration platforms.
Implementation
Architecture
LabKey Server is a web application implemented in Java
that runs on the Apache Tomcat web server and stores
its data in a relational database engine, either Post-
greSQL or Microsoft SQL Server. An earlier version of
the platform was called CPAS (Computational Proteo-
mics Analysis System) [49]; the current version includes
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Figure 1 The Atlas data repository. Atlas facilitates collaboration
among scientists, clinics and labs distributed across the globe by
acting as a centralized, integrated, secure data repository. It
currently serves the following members of the Global HIV Vaccine
Enterprise: the Center for HIV Vaccine Immunology (CHAVI), the
Collaboration for AIDS Vaccine Discovery (CAVD), the HIV Vaccine
Trials Network (HVTN), the Microbicide Trials Network (MTN), the
Vaccine Immunology Statistical Center (VISC) and the HIV Prevention
Trials Network (HPTN).
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on computers running Microsoft Windows and most
Unix variants, including Linux, Macintosh OSX and
Solaris. Production installations can be upgraded in
place with minimal down time. Some installations are
run as software-as-a-service (SaaS), which moves server
management out of the lab.
Figure 2 shows that the system consists of core ser-
vices, including data storage, file management and
security, together with specialized modules. LabKey Ser-
ver modules support specific scientific scenarios by
encapsulating application logic, user interfaces and data.
Data can be shared and integrated across modules.
Modules can be added, upgraded, distributed or
removed independently, allowing the addition of new
analytic capabilities, support for new types of data or
other features. On an individual basis, they can be kept
private within an institution or contributed to the Lab-
Key Server open source project.
Datasets that reside in external repositories can be
made directly accessible through a LabKey Server.
Access to such datasets is dynamic, meaning that any
modifications to such datasets within an external reposi-
tory are immediately viewable on the associated LabKey
Server. Dynamic access can be configured for Post-
greSQL, MySQL or Microsoft SQL Server databases, or
for other data sources such as SAS [50]. In general,
users can work with data from external sources just like
any other type of data on a LabKey Server. Authorized
users can view shared datasets using LabKey Server’s
familiar, accessible grid user interface. Users can custo-
mize their views with filters, sorts and column lists.
They can use the datasets in custom queries and
reports, or export the data to Excel, web query, or
simple text formats. For data sources other than SAS,
changes can be made to datasets in the external reposi-
tory using the LabKey interface. While datasets from
any one data source can be joined to each other, data-
sets from different data sources cannot yet be joined
directly.
Basic Platform Services
LabKey Server’s role-based security model allows tight
control of access to sensitive data while permitting
broad sharing of content when this information is ready
for wider release [49]. Users can be assigned specific
permissions outside of their groups and roles, allowing
fine-grained control of access. Workspaces on a LabKey
Server are arranged hierarchically and permissions can
be inherited by children. Permissions are enforced no
matter how information is accessed, including full-text
search, data export and the LabKey API (Application
Programming Interface). Updates to administrative set-
tings and scientific data on a LabKey Server are logged,
enhancing security and enabling auditing.
Authentication of users occurs either through LabKey
Server’s core authentication system or through external
authentication systems. A LabKey Server installation
may optionally connect to an LDAP (Lightweight Direc-
tory Access Protocol) server to automatically authenti-
cate users within an organization. LabKey Server also
supports Single Sign-On (SSO) through OpenSSO [51],
allowing authentication of users from a partner web site.
The system provides full-text search for most types of
data and documents, plus “science-aware” search for
relevant concepts, particularly participant identifiers and
study properties. A server can also be configured to dis-
play search results from external web sites. LabKey Ser-
ver also provides a variety of web-based collaboration
tools, including file management, wikis, message boards
and issue trackers [49].
Automated exception reports are generated by LabKey
Server installations and reported back to LabKey Soft-
ware. By monitoring exception reports, the LabKey team
can quickly fix issues and publish patches without the
need for users to report these problems.
Customizable Data Types
A key challenge of scientific data integration is the
diversity and the rapidly changing nature of the data
types that must be integrated. LabKey Server meets this
challenge by combining the flexibility and rich metadata
capabilities of RDF (the semantic web’sR e s o u r c e
Description Framework) [52] with the regular structure
and familiar query mechanisms of a SQL (Structured
Query Language) database.
The semantic web defines a network of interconnected
resources, each of which can be uniquely identified by a
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Figure 2 LabKey Server’s modular architecture.L a b K e yS e r v e r
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add new functionality.
Nelson et al. BMC Bioinformatics 2011, 12:71
http://www.biomedcentral.com/1471-2105/12/71
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described by a set of properties and property values.
Because the properties and property values are them-
selves resources, rich data and metadata can be assigned
to every resource. Following the semantic web model,
data items stored in a LabKey Server can be addressed
with a URI in the form of a Life Sciences Identifier
(LSID) [53]. Furthermore, they can be associated with
an extensible set of properties known within a LabKey
Server as fields.
LabKey Server provides a set of basic, predefined data
types that can be extended with custom, administrator-
defined fields. These data types include lists, assays,
study datasets, and specimens. Fields may include stan-
dard SQL data types, such as string and numeric types,
but may also use semantically richer property types
designed for scientific research, such as participant iden-
tifiers. Fields can be associated with other scientifically
interesting properties, such as out-of-range values, cus-
tom indicators for missing values, regular expression
validators and custom URL templates for generating
hyperlinks to external or internal resources. Fields can
also be annotated to indicate that they represent con-
cepts described in curated ontologies, such as those pro-
vided in UMLS (Unified Medical Language System) [54].
LabKey Server also allows administrators to define
lookup properties that behave as foreign keys and allow
automatic joining of related data.
Query Service
All LabKey Server data types benefit from a core query
service that allows users to browse, sort and filter tabu-
lar data. This service is diagrammed in Figure 3. It sup-
ports a graphical interface that allows users to create
customized data views and save these views for reuse
and sharing with other users. LabKey Server’sb u i l t - i n
tools for creating R views, building crosstab views and
drawing simple charts all leverage the query service.
The query service also allows developers to write full
SQL queries that can be executed by other users.
Finally, the service provides the ability to export tabular
data in a variety of formats for analysis with external
tools.
To maintain security, the query service interprets
these queries and executes them over a virtual database
schema that reflects the permissions of the currently
logged in user. For example, the system can perform
cohort blinding by prohibiting particular users from
viewing data columns that would reveal the cohorts of
participants. Similarly, if a clinician holds permissions
sufficient only for viewing data for locally enrolled parti-
cipants, the clinician can only access views that are cus-
tomized to hide data rows for all other participants.
Results
Recent enhancements to the LabKey Server platform
enable four core scenarios, all of which have contributed
to the success of Atlas. Full documentation and tutorials
for LabKey Server are available at http://www.labkey.org.
Scenario 1: Specimen Requisition and Tracking
LabKey Server’s specimen management system provides
more than a centralized repository of specimen informa-
tion. It also supplies secure, web-based tools for request-
ing, approving and tracking specimen transfers between
clinics, repositories and labs. Centralized specimen
information can be annotated and integrated with clini-
cal, assay or other data for study participants or animal
subjects to allow comprehensive analyses.
Figure 4 walks through typical steps for importing
specimen information and configuring the request pro-
cess. Figure 5 reviews a simple usage scenario, including
searching for available specimen vials, joining specimen
data to related data and requesting specimens using the
specimen shopping cart.
LabKey Server also includes built-in tools for building
specimen summary reports that allow data managers to
leverage the centralized availability of information about
specimens. Reports can be parameterized by the type of
specimen, date of collection, availability of vials, source
participant in the study, cohort of the participant, cur-
rent location and other measures.
This specimen management system is complemen-
tary to pre-existing, site-specific tools. Most labs
already have LIMS, such as LabWare [55] or the Fron-
tier Science Laboratory Data Management System
(LDMS) [56], for specimen management. These LIMS
are typically set up with freezer layouts, technician
identities, mailing addresses, workflow info, and the
like. The LabKey specimen management system does
not aim to replace lab-specific LIMS; instead, it serves
to connect them. Cross-site specimen management is
typically a missing piece for LIMS that handle speci-
mens, so LabKey helps consortia to “glue together”
their LIMS through cross-site tracking of specimens
and specimen requests.
Members of the Enterprise use Atlas heavily for both
specimen request management and integration of speci-
men data with other types of data. The system records
approximately 860,000 specimen vials and 1,300,000 vial
transfers. Additional usage statistics are covered in the
“Atlas Usage” section of this document.
Scenario 2: Management of Experimental Data
Typically, labs manage new types of experimental data
in spreadsheets, but this can quickly become unsustain-
able as results proliferate. LabKey Server provides
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assay data that would otherwise reside in a multiplicity
of spreadsheets. These tools make it easier to bring data
straight from the bench into a common system, mini-
mizing the cost of centralizing data, preserving data pro-
venance information, enhancing standardization of data
collection and enabling data integration. Assays can also
be customized through the LabKey client libraries to
include specialized analysis capabilities.
Lab data managers define custom assay “designs” to
formally describe experimental results, then import
many sets of experimental results to a LabKey Server
using the formats specified in the designs. The structure
of an assay may include the number of input samples;
the type and format of experimental result files; and the
definition of summaries or visualizations appropriate for
sharing.
Defining experimental properties in the form of an
assay design helps to ensure that appropriate data points
are collected for each experimental run or set of runs
loaded into the server. For any manual data entry steps,
LabKey automatically generates the appropriate data
entry pages based on the assay design. The design deter-
mines which data entry elements are required and which
are optional. A lab technician can also use the assay
design to set appropriate default values for data items or
provide pick-lists of standard values. This reduces the
burden of data entry and the incidence of errors.
Customized assay designs can be based on a general
template, or on specialized assay types that are added to
the LabKey platform as modules. Specialized assay types
currently include: neutralizing antibody (NAb); enzyme-
linked immunosorbent spot (ELISpot); microarray;
Luminex; cell recovery and viability; complete blood
count; particle size, high performance liquid chromato-
graphy; and enzyme-linked immunosorbent assays
(ELISA). Some of these have been developed to match
the structured output of tools used by existing platform
users, so they can be instrument-centric. Just like Lab-
Key Server’s proteomics and flow cytometry tools
[49,57], all assay types are backed by a common experi-
mental design architecture that defines notions of
experiments, runs, batches (groups of runs), protocols,
inputs, outputs and materials (specimens, samples or tis-
sues) [49].
Assay run creation and deletion are audited and run
data cannot be modified after runs are imported. Anno-
tations can be added to assay runs through the user
interface or programmatically through quality control
scripts. LabKey Server’s assay infrastructure can support
GCLP (Good Clinical Lab Practices) [58] and the estab-
lishment of repeatable, reliable, auditable and compar-
able lab procedures.
Figure 6 shows typical steps for designing an assay,
while Figure 7 shows typical steps for populating the
same assay design.
LabKey Server’s neutralizing antibody assay provides
an example of how the system’sa s s a yt o o l sc a ne n c o u -
rage process standardization across labs and catalyze
contribution of data to a central repository for integra-
tive analyses. The NAb assay tool included in the
LabKey platform was developed to formalize data man-
agement for the TZM-bl NAb assay [59]. Replacing a
spreadsheet macro, it simplifies data processing by
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columns from related tables. ￿ A SQL query based on pseudo-tables known to the query service. For an API call, the following sequence of
events occurs: 1. When the request is received by the server’s API layer, the layer checks folder security and translates the request into calls to
the query service. 2. The query service then uses schema information describing physical tables and pseudo-tables to translate the input query
into a SQL query of physical tables. The query is formulated in the dialect understood by the underlying relational database. Schema information
is supplied by other LabKey modules. 3. The database returns a tabular result. 4. The tabular result is annotated with additional information
about the columns (e.g. user-friendly label, description and formatting hints). 5. The appropriate LabKey client library converts this standard data/
metadata into a form easily understood by the client language. For example, an R dataset would be returned as the result of a call by an R
client API.
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Page 7 of 23providing an automated system for uploading, trans-
forming and analyzing data and displaying results
(shown in Figure 8) through a web-based interface. Data
from the plate reader and metadata describing the
experiment are imported to the server, where calcula-
tions are done automatically and results can be visua-
lized and shared.
As part of Atlas, the NAb tool has been used success-
fully by 14 labs across 4 organizations within the Enter-
prise (CHAVI, VISC, HVTN and the U.S. Military HIV
Research Program). As of May 2010, these labs have
used the NAb assay tool to upload and store over
25,000 NAb assay runs. The labs use the tool not just
because it enables data transfer, but because it provides
immediate value. The tool provides technicians with
graphical feedback that indicates whether results fall
within expected bounds, and thus whether the assay has
been performed correctly. The use of the NAb tool
facilitates standardization, organization, auditing and
integration with other types of repository data, such as
specimens.
Scenario 3: Data Integration
Users of LabKey Server can draw together information
stored in multiple tables using built-in summary views,
a graphical cross-source view designer and custom SQL
queries. Datasets are typically connected through shared
identifiers for subjects (e.g., participant, animal or sub-
ject identifiers), samples (e.g., specimen identifiers) and/
or time points of data collection (e.g., participant “visits”
to clinics). However, tables do not need be related
through these types of identifiers to be joined into com-
mon views; they may also be joined through administra-
t o r - d e f i n e dl o o k u pf i e l d s .J o i n e d ,i n t e g r a t e dv i e w s
can be used as the basis for complex analyses and
visualizations.
A
B
D
E
C
Figure 4 Typical setup steps for specimen tracking and requests. 1. An administrator sets up a folder to display the “Specimens” web part
and configures permissions for those who will be interacting with specimens. The administrator then imports an initial archive of specimen
records and information about repositories and sites. A populated “Specimens” web part is shown in A. 2. A specimen data manager configures
the specimen request process, including configuring request steps (B), identifying actors in the request process (C), configuring requirements for
request approval, and setting up notification procedures (D).
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Page 8 of 23Figures 9 and 10 show how LabKey Server’sg r a p h i c a l
tools and R can be used to join, analyze and visualize
data from multiple source tables based on participant/
visit identifiers. Figure 11 shows how the system’sc u s -
tom view designer can construct a joined view by means
of a user-defined lookup relationship between two
tables. Figure 12 shows how LabKey Server’s SQL editor
enables the construction of more sophisticated queries,
including the inclusion of calculated columns and cus-
tom metadata. All of these figures use made-up data.
On a LabKey Server, a folder-based “study” serves as the
primary integration point for connecting heterogeneous
data types collected as part of an observational study. A
study defines built-in relationships between study data
entities (shown in Figure 13) and provides built-in tools
for summarizing and visualizing related data.
A B
C
D
Figure 5 T y p i c a ls t e p sf o rv i a ls e a r c ha n dr e q u e s t . 1. A scientist logs on the system from a participating lab, then searches for vials or
specimens of interest, as shown in A. 2. To further narrow down the possible vials of interest, the scientist builds a custom view of the subset
of vials she has identified through search. This custom view integrates information from diverse sources using shared identifiers. In the example
shown in B, shared participant and visit identifiers are used to join in data from a related dataset. In this case, the gender of the participant who
provided the sample (as defined in a separate, demographic dataset) is drawn into the vial data view. 3. The scientist then creates a new
specimen request and uses the “specimen shopping cart” to add desired vials to this request, as shown in C. 4. When finished, the scientist
submits the finished request, as shown in D. 5. Designated reviewers are notified of the requests and approve them. 6. Specimen repository
workers are notified of the approved requests, fill the requests and update the web-based interface. Vial(s) that have been used are no longer
requestable. 7. After receiving a specimen vial, the scientist performs an assay on the specimen. Results from this assay may be marked with the
vial identifier or participant/visit identifiers so that they can be associated with specimen information on the LabKey Server. The process for
associating assay results with specimens is shown later in Figure 7.
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Page 9 of 23Figure 14 shows how data flows into a study in many
forms (e.g., Excel, text and DataFax case report forms)
from many sources (e.g., labs, clinics and repositories),
where it can be combined and consumed in different
ways by collaborators (e.g., labs, principal investigators
and statisticians). For example, labs might use aggregated
data to identify issues with quality control methods,
while statisticians might apply novel transformations in
R, while principal investigators might monitor overall
progress of cohorts through summary views. Studies also
provide mechanisms for formalizing data approval prior
to sharing and integration; adding “quality control” anno-
tations at the level of datasets or data points; exercising
fine-grained control over dataset security; grouping sub-
jects by cohort; enforcing cohort blinding; summarizing
data by participant or other measures; and exporting/
importing/reloading entire studies for efficient backup,
staging or transfer to new locations.
Figure 15 shows a typical study portal page that lists
the datasets and specimens associated with the study.
Figure 16 shows the system’s built-in interface for view-
ing all study datasets available for a particular individual
across all visit dates.
Atlas exemplifies how a LabKey Server can draw upon
both LabKey-based data and data from external systems
to support observational studies. Atlas’s flexibility in
interfacing with external databases allows it to be differ-
ent things to different types of data – a database of
record, an integration point, or both. Atlas interacts
with several SAS and PostgreSQL databases in real time.
It also imports data exported from other data sources,
particularly a database of DataFax case report forms,
and deposits data into relevant Atlas-based studies. For
certain types of data (e.g., specimen requests), Atlas is
the database of record. For others (e.g., specimen cell
counts), Atlas is simply the integration point for diverse,
specialized databases of record.
Scenario 4: Extensibility
LabKey Server’s deep support for customization and
rapid application development frees labs to indepen-
dently adapt their servers, interfaces and analyses
to lab-specific needs. Client libraries in a range of lan-
guages, plus a user interface for R scripting, allow
investigators to use familiar tools to build custom
applications, interfaces, assays, reports and analyses.
Developers can add larger features by encapsulating
them in modules, create individual data views in R or
simply add API-enhanced content to wikis or HTML
pages in the file system.
LabKey Server’s client libraries are backwards-compa-
tible, well-documented and designed to be accessible to
developers with varied skill sets, from Java programmers
to R scripters. The client libraries provide programmatic
access to LabKey Server modules and services (shown in
Figure 2) through familiar languages such as JavaScript,
Java, R, SAS and Perl. Developers who prefer other lan-
guages, such as PHP, can interact with a LabKey Server
through JSON over HTTP. Familiarity with LabKey
Server’s object model is not necessary to quickly pro-
duce useful applications.
Figure 6 Typical steps for designing an assay.1 . A n
administrator creates an assay-type folder to act as a staging area
for assay data before the data has undergone quality control. 2. A
scientist creates a new assay design to match the contents of
experimental results stored in spreadsheets. In this example, the
assay design is based on a generalized assay template, but other
assay types could be used. The assay design is named
“GenericAssay,” as marked by A. 3. The scientist then adds a set of
batch fields that must be filled out when each batch of runs is
imported. User-defined batch fields are backed by the same set of
customizable properties as system-defined fields. This image shows
label, description, type, lookup and custom URL properties for
several fields. Other properties include conditional formatting,
default values and regular expression validators. Here, the “Machine”
batch field (B) is configured (in popup C) as a lookup to a simple
list ("Lab Machines”). At the time of data import, the user will be
presented with a defined list of options for populating the
“Machine” field that are drawn from the primary keys of the
“Machines” list. 4. Next, the scientist defines the run fields (D) that
must be collected for each run. In this example, only one field
("MachineSetting”) is defined. 5. Finally, to save time, the scientist
infers the assay’s data fields (E) from a representative spreadsheet
file. These fields could also have been designed manually, in the
same manner as the batch and run fields.
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missions to select, insert, update and delete records on a
LabKey Server. The JavaScript library also includes APIs
for building user interfaces and executing actions com-
monly performed through the user interface. These
include adding web parts, adding users or groups,
checking permissions, executing SQL queries, populating
datasets, sorting and filtering grid views, requesting spe-
cimens, adding folders, building charts, navigating, and
building interactive grid views, among many other
actions. For example, the entire process of populating
an assay (as shown in Figure 7) can be accomplished
through the JavaScript client library.
LabKey Server provides multiple of methods for work-
ing with R. Users can employ the R client library to load
live data from a LabKey Server into an external R envir-
onment for analysis, provided the user has permissions
to read the data. The R library also supports querying
for available data, then inserting, updating, and deleting
data records, given sufficient user permissions. In addi-
tion to the R client library, the system provides an inter-
active R scripting interface that allows users with
appropriate permissions to author scripts, view script
results and see source data, as shown in Figure 10.
Lastly, R scripts can be included as files in custom mod-
ules to define custom views for custom queries.
A
B
C
D
E
Figure 7 Typical steps for populating an assay. 1. The user selects the assay design that matches experimental data and chooses to
sequentially import run data. This example uses the assay design from Figure 6. 2. For each batch of data, the user is prompted for batch
properties (A). Here, the “Machine” options are provided as a defined vocabulary to reduce errors and variability in data entry. 3. For each run,
the user is prompted for run properties and run data (B), as described in the assay design. A template of expected columns can be exported to
help with matching data formats. 4. The user can import several runs sequentially using the same batch properties. C shows a summary view of
the three runs that have been imported to this assay design using the same batch properties. 5. D shows an example of results imported as a
single run for this assay. Note that the “Machine” column is defined as a lookup to another table, so each of its entries is hyperlinked to details
for the appropriate machine, as provided by the “Lab Machines” list. 6. After assay data has been reviewed for quality control, it can be moved
into a study folder for sharing with collaborators and integration with other types of study data. During the import process, the participant/visit
identifiers for each row of assay data are matched (E) to identifiers for specimens in the target study. This allows viewers of the assay data
within the study to quickly navigate to data for associated specimens.
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Page 11 of 23The SAS client library provides very similar function-
ality to the R client library, enabling interaction with
LabKey Server data from SAS.
At present, the JavaScript client library is LabKey Ser-
ver’s most fully featured. While the actions available
through its APIs are broad and deep, they are not yet
completely comprehensive. For example, it is possible to
define a new assay type (e.g., a new plate-based assay
like the NAb assay) using the client libraries, or to
populate an existing assay design (as shown in Figure 7),
b u ti ti sn o ty e tp o s s i b l et oc r e a t ean e wa s s a yd e s i g n
based on an existing assay type, as can be done through
the user interface (shown in Figure 6). Due to high
interest among user-funders, LabKey Server’sc l i e n t
libraries are expanding quickly.
SCHARP developers have leveraged LabKey Server’s
client libraries extensively to quickly meet the needs of
evolving studies. For example, a custom application built
on Atlas was used for adjudicating the results of the
Thai Phase III HIV vaccine study, also known as RV144
[60]. This trial provided the first modest demonstration
of a positive effect for an HIV vaccine. An independent,
globally distributed committee judged participant HIV
status during this trial by evaluating Western Blot
images and other data through the Atlas interface.
Using Atlas, committee members travelling between
research sites could log on to a web-based interface
from locations across the world, view images and enter
findings. The process was formerly conducted through
postal mail. A single developer created the custom
RV144 reporting tool in JavaScript in a matter of weeks.
The tool is available only on Atlas.
HTVN has built custom data summaries (available
only on Atlas) that allow central labs to view the cumu-
lative success of individual technicians in processing and
preserving blood cells, as measured through cell viability
tests. Study managers can use these summaries to
swiftly identify problem areas and improve quality con-
trol. The result is a shorter feedback loop between cen-
tral labs and remote labs. The summaries also provide
transparency to project funders and digital historical
records that take the place of paper-based tracking.
Figure 17 shows how Atlas developers have used
LabKey Server’s client libraries to build custom, gra-
phical interfaces that enable users who are not skilled
in R scripting to generate custom R views. It shows
one such interface, plus an example of the type of R
view it produces. Figure 18 shows customized, partici-
pant-specific views built by Atlas developers using Lab-
Key Server’s R interface and JavaScript client library.
Figure 19 shows an example of a custom interface
defined in a module developed specifically for Atlas.
This module defines a custom reporting tool that pro-
vides interactive summaries of vaccine studies. It
allows users to selectively view information of interest
and provides interfaces that roll up summary data for
each study. All of interfaces shown in Figures 17, 18
and 19 are available only on Atlas because they are
specific to the data Atlas contains.
Figure 8 Detailed NAb assay results view. The “details” view for a
NAb assay visualizes measures of neutralization success and
provides several calculations for areas under the neutralization
curve.
Figure 9 Example of joining datasets based on built-in
relationships. Results from related data sources can be joined into
a common grid view using built-in relationships between study
entities. Here, the grid view customization tool is used to pull in
columns from data sources that include the same participant/visit
pairs. The results of an assay ("Lab Results”) are joined with the
columns from another assay ("HIV Test Results”) and the results of a
physical exam ("Physical Exam”). The joined custom view can be
saved privately, made visible to collaborators or exported in various
formats, including Excel.
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The ability of LabKey Server to meet core scientific and
data management needs in a customizable way is
demonstrated by the adoption of the platform by a
range of organizations beyond the Enterprise. According
to data reported automatically by active LabKey Servers,
approximately 40 installations are currently in active
use. LabKey Server v10.3, available in November 2010,
is the 19
th official, public release of the platform.
Adoption of the platform has also meant adaptation;
research organizations use LabKey Server for a wide
range of purposes. For example, several labs use their
installations of LabKey Server to manage the large
quantities of data that stream from flow cytometry [57],
proteomics [61-64] and/or microarray [61] experiments.
Two systems biology labs use LabKey Server to integrate
d i v e r s ed a t at y p e sa tt h el a bl e v e l[ 6 1 , 6 2 ] .T h eN a t i o n a l
Primate Research Center at the University of Wisconsin,
Madison, is customizing a LabKey Server installation to
provide an extensible, life-science-aware database for
non-human primate electronic health records. These
features are being developed as a custom module for
LabKey Server that will be available to other researchers.
The Primate Center also uses LabKey Server for multi-
plexed genotyping and next-generation sequencing
experiments. A distributed team of cancer researchers
A
D
B
C
Figure 10 Examples of analyzing and visualizing a joined custom view.H e r e ,t h ej o i n e dc u s t o mv i e wc r e a t e di nF i g u r e9i su s e dt o
construct a participant chart (A), crosstab view (B) and R chart (C and D) through the “Views” menu available above the joined grid. A. The
participant-specific chart view marked by A displays the same type of information for each study participant, in sequence. Users can toggle
between the displayed chart and its associated dataset using the “View” and “Data” tabs. This particular chart displays the progression of HIV viral
loads and CD4+ counts over time for each study participant. B. A crosstab view like the one shown in B could be used to verify that different
tests for determining HIV status produce consistent results. C. The R script displayed in the “Source” tab of the R script editor (C) uses data from
the joined custom view to compare how CD4+ counts and HIV viral loads change over time. The scripting environment makes the source
dataset available as the labkey.data data frame, as circled in red. D. The results of the script are displayed by selecting the “View” tab of the R
script builder, as shown in D. Selecting the “Data” tab would display the source dataset (not shown). R views, just like other views, can be saved
privately or made visible to collaborators with sufficient permissions to view the source data. Within LabKey Server’s R environment, users can
also invoke stored scripts and leverage advanced analysis or visualization packages, such as those provided by Bioconductor[80].
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Page 13 of 23based at the Fred Hutchinson Cancer Research Center
uses a LabKey Server as a place for “virtual research.”
Team members consolidate data from existing, online
databases onto their LabKey Server and then use R to
collaboratively mine this data. Two labs use LabKey Ser-
ver for post-publication sharing [61,63]. AdaptiveTCR, a
T-cell sequencing company, has used LabKey Server to
build a customized, proprietary system that allows cus-
tomers to purchase analyses, submit specimens, view
results and interactively visualize data [65]. Insilicos, a
company focused on proteomics, uses LabKey Server to
support cloud-based, scalable computing [66].
Atlas Adoption
Atlas’s success in achieving adoption across the Enter-
prise can be gauged by considering usage statistics for
the system. The number of accounts (approximately
2,800 accounts across 350 organizations and 36 coun-
tries) is notable given the relatively high bar for gaining
access to the system, as compared to open-access data-
bases that publish fully anonymized data. Access is
restricted due to privacy considerations for clinical stu-
dies on a sexually transmitted disease.
Atlas held 2,844 active user accounts in May 2010.
The number of individual users likely lies closer to
2,800 because some users (particularly administrators)
hold multiple accounts. Approximately 600 additional
accounts have been deactivated (as typically happens
when an individual leaves a position), so approximately
3,400 total accounts have existed on the system. The
first user account on Atlas was created on October 4,
2005.
Approximately 350 distinct organizations are represented
among user accounts. Roughly 200 distinct organizations
have two or more active Atlas users while approximately
100 distinct organizations have five or more users.
Approximately 36 countries are represented among
user accounts. The number of accounts associated with
each country suggests the degree of usage in each coun-
try. 29 countries were associated with two or more user
accounts while 23 countries were associated with five or
more accounts.
As of May 2010, Atlas holds 26,684 uploaded assay
runs, 2,637 customized data views, 2,116 unique wiki
pages and 1,717 message board posts. Also as of May
2010, Atlas has tracked 156,349 specimens (such as
Figure 11 Example of joining data sources through a user-defined lookup relationship. The “Lab Machines” list, a simple table, was used
in Figure 6 to provide a defined vocabulary for populating the “Machine” batch field of the “GenericAssay.” The “Machine” batch field was
defined as a lookup to the “Lab Machines” list. The existence of this lookup relationship allows us to join machine information into grid views of
assay run data. Here, as circled in red, the relevant machine’s “Contact Person” is joined into a grid view of assay results.
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Page 14 of 23blood draws or urine specimens). These have been sub-
divided into 859,759 vials and transferred during
1,280,407 specimen “events.” Events record transfers of
all types, including active requests for vials (made
through the Atlas interface) and transfers without
request (such as automatic transfer of vials from clinic
to repository after collection). A total of 801 requests
have been entered and processed through Atlas, result-
ing in the transfer of 19,727 individual vials. Each
request typically includes multiple vials.
During April 2010, the Atlas web site welcomed 1,400
unique visitors from 36 countries. The average visit
included 13 page views over 11 minutes. Overall, a total
of 5,400 site visits produced 70,000 page views during
B
A
Figure 12 Example of creating a custom SQL view. This figure demonstrates how a custom SQL view can add a calculated column to a
joined view and label the column using custom metadata. Part A of this figure shows LabKey Server’s schema browser, which allows a
developer to view, add or edit custom queries. Part B shows how the SQL source editor has been used to add a calculated column to a table as
part of a custom query. It also shows how the table metadata editor has been used to edit the column’s properties and add a custom title. The
grid view produced by this custom query is shown in C.
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Page 15 of 23this time period. These statistics are typical of recent
months. The number of countries where visits origi-
nated was the only measure that notably increased over
the past six months (from 27 to 36).
Discussion
Lessons Learned
Adopting a shared platform like LabKey Server to accom-
plish data integration and process standardization can
bring network benefits to collaborating organizations.
At the same time, achieving adoption of a new platform
across a diverse community is not an easy task, even
when the community is joined together into a common
effort such as the Enterprise. As we have learned first-
hand, merely providing innovative software features is
insufficient-the real challenge is making the software use-
ful to scientists.
Other researchers have proposed general principles for
developing software for biologists [67-71] or for speed-
ing the broad adoption of innovations [72,73]. However,
relatively few [13,74] have explored development guide-
lines that facilitate adoption of software across biomedi-
cal research organizations. We attribute adoption of
LabKey Server and Atlas primarily to the use of seven
successful development strategies:
(i) Enable easy extensibility and customization of
interfaces, analyzes and visualizations.S c i e n t i f i c
insights often come from nonstandard approaches,
so scientists have a natural preference for software
that can be customized to the particular needs of
their labs. Tools for rapid customization have proven
particularly important to both the adoption of Atlas
and the dissemination of LabKey Server. For example,
SCHARP’s development of custom applications on
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Figure 13 Simplified study schema. This simplified schema
outlines the relationships between entities in a study. Data tables in
a study can be integrated when they contain shared quantities,
such as participants, visits or specimens.
Data Viewers
Labs
LabKey Server
Assays
Leads, Analysts
Sites
Labs
Sites
Sample Info
labid uspeci txtpid parusp drawdm drawdd drawdy
262 4633 9.99E+08 4632 3 23 2005
308 13472 9.99E+08 13471 3 23 2005
262 4641 9.99E+08 4640 4 14 2005
262 4650 9.99E+08 4649 5 9 2005
262 4652 9.99E+08 4651 5 11 2005
308 13480 9.99E+08 13479 5 11 2005
262 4668 9.99E+08 4667 4 13 2005
308 13486 9.99E+08 13485 4 13 2005
262 4684 9.99E+08 4683 5 11 2005
262 4751 9.99E+08 4750 6 21 2005
308 13560 9.99E+08 13559 6 21 2005
262 4769 9.99E+08 4768 6 28 2005
308 13578 9.99E+08 13577 6 28 2005
262 4850 9.99E+08 4849 6 1 2005
262 4897 9.99E+08 4896 8 17 2005
262 4898 9.99E+08 4896 8 17 2005
262 4914 9.99E+08 4913 8 30 2005
308 13933 9.99E+08 13932 8 30 2005
262 4922 9.99E+08 4921 9 1 2005
308 13941 9.99E+08 13940 9 1 2005
262 4934 9.99E+08 4933 9 14 2005
308 13953 9.99E+08 13952 9 14 2005
262 4935 9.99E+08 4933 9 14 2005
308 13954 9.99E+08 13952 9 14 2005
262 4950 9.99E+08 4949 9 28 2005
308 13969 9.99E+08 13968 9 28 2005
262 4951 9.99E+08 4949 9 28 2005
308 13970 9.99E+08 13968 9 28 2005
307 773 9.99E+08 772 8 24 2005
307 774 9.99E+08 772 8 24 2005
307 800 9.99E+08 799 8 30 2005
307 801 9.99E+08 799 8 30 2005
Data Providers
Data FAX
DOB
BP sys
BP dia
Notes
QA
QA
QA
Data Repository
(Portal)
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Figure 14 LabKey Server data flows. Data flows into a LabKey Server from diverse sources, undergoes quality control and becomes available
to a range of data customers through a web-based portal.
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Page 16 of 23Atlas only took off with the release of LabKey Server’s
first client API. Before release of this API, develop-
ment of custom interfaces typically required assis-
tance from LabKey Software engineers. Furthermore,
system-level APIs changed often, so custom applica-
tions usually broke upon upgrade. Over the first 2.5
years of the life of Atlas (October 2005-May 2008),
SCHARP created only 6 custom applications using
system-level APIs, for an average of 2.4 per year. In
contrast, in the first 18 months after the release of
LabKey Server’s JavaScript API (May 2008-October
2009), 240 SCHARP-authored applications and tools
went live on Atlas, for an average of 160 per year.
(ii) Add value at the level of the lab bench, not
just the overall Enterprise, to entice users to
bring data into the system. Labs are more willing
to adopt new data management practises if adoption
makes their own work more efficient, standardized
and/or reproducible. LabKey Server’s TZM-b1 neu-
tralizing antibody tool has met wide adoption
because it brings immediate value to front-line labs.
It translates key lab workflows into standardized
data management practises that enhance efficiency
and reproducibility. In contrast, adoption of LabKey
Server’s Luminex assay tool has been slow because
the tool does not provide a clear, direct benefit to
labs. It was designed primarily to help labs put their
data into a format useful to central data managers.
Only 120 Luminex runs were uploaded to Atlas
between February 2008 and January 2011 (roughly
40 per year); for comparison, approximately 40,000
NAb runs were uploaded from December 2006 to
January 2011 (roughly 9,800 per year).
(iii) Interoperate easily with existing, external
data sources. Easy interoperability enables data inte-
gration without the need to first transform a LabKey
Server into the primary or archival repository. For
example, LabKey Server is not the database of record
for Enterprise specimens. Instead, the Atlas installa-
tion of LabKey Server synchronizes with existing
LIMS systems. This allows members of the Enter-
prise to retain existing workflows and avoid transfer-
ring legacy data to a new platform. Given the extent
of existing systems, the development of Atlas is unli-
kely to have occurred without interoperability.
(iv) Practice agile [75], interdisciplinary software
development to continually incorporate user feed-
back. Close collaboration between data managers,
research scientists and independent software
engineers ensures continual focus on actual, not the-
oretical, user needs. The team uses short, four
month release cycles and a formal feature review
process to tighten the feedback loop. Notably, the
features that have received the most user feedback
Figure 16 Participant-specific data summaries. A data overview
is provided for each participant in a study. It displays all datasets in
the study associated with a particular participant across all visit
dates. Participant-specific charts can be displayed for each dataset,
as shown for the “Physical Exam” dataset. A user can navigate
through equivalent views for other individuals using “Next
Participant” link and “Previous Participant” links.
Figure 15 Study portal page. A study portal provides a jumping-
off point for investigating patterns in shared datasets. The interface
can be customized to list the different types of data or views
available in the study and to display custom data tables or
visualizations. The “Study Navigator” shown in this figure is a data
summary tool that rolls up information from many study datasets
based on participant identifiers.
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Page 17 of 23during design and development (e.g., the TZM-bl
neutralizing antibody assay, specimen management
and API libraries) have become the most widely
used tools. Features that did not have significant
end-user involvement in the design process (e.g., the
ELISpot assay tool) have experienced the slowest
adoption. Notably, not a single ELISpot run has
been uploaded to Atlas since the initial release of
the tool in May 2008.
(v) Use a platform-based approach to meet shared
needs cost-effectively.T h eL a b K e yt e a mw o r k st o
identify common, long-term requirements for the
platform so that the core system features it builds (e.
g., the assay designer and tools for file management)
meet shared needs using common infrastructure.
New, specialized applications can simply leverage
these core platform services. This lowers costs,
reduces bugs and increases the speed of develop-
ment. As we have learned, straying from a long-term
approach (e.g., building a new assay outside of the
generalized assay infrastructure) makes certain fea-
tures (e.g., integration of this assay with sample man-
agement) cost-prohibitive.
(vi) Ensure that cross-disciplinary facilitators have
bandwidth for adoption. SCHARP data managers
have played a particularly important role in the suc-
cess of Atlas. They have combined their understand-
ing of research objectives with their knowledge of
Atlas capabilities to facilitate the upload and effec-
tive use of data, cementing adoption. For new instal-
lations of LabKey Server, successful adoption has
often been attributable to a primary champion in a
lab who has set aside sufficient time to become a
skilled user of the platform. Without in-house advo-
cates and experts, adoption has often faltered.
(vii) Establish a reliable track record for ongoing,
professional development, maintenance and sup-
port. Don Listwin of the Canary Foundation has
A
B
Figure 17 A custom, interactive form for designing an R view.P a r tA of this figure shows an example of an interactive R chart designer.
This particular interface (available only on Atlas) was created using the LabKey JavaScript client libraries. It allows users to create custom views
of antibody binding data. Users employ a graphical form to select participants of interest, isotypes, antibodies and groupings for plots. The form
sends user selections to a parameterized R script that runs on a joined view of relevant datasets. Part B of this figure shows the R view
produced by this form. It shows binding antibody graphs by isotype (interferon alpha (IgA) and interferon gamma (IgB)) for two study
participants. The graphs plot glycoprotein 41 reading values (GP41) and viral loads for each participant and each isotype against the number of
days that have passed between enrolment of the participant in the study and the collection of the tested specimen. Participant identifiers in this
figure have been modified to hide study participant identities.
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Page 18 of 23quipped: “[Scientific] open source software has the
half life of a graduate student” [76]. Given this type of
scepticism and the resources required for adoption, it
is particularly important to use development practises
that build confidence in the longevity of the system.
The LabKey Software team has used decades of
experience in building commercial software to estab-
lish enterprise-calibre development practices for
design, testing, stabilization, deployment and support.
Some practises, such as automated exception report-
ing and public transparency, go beyond those com-
mon in the industry. Official builds of the platform
are released with regularity, three times per year.
Limitations of LabKey Server
Most biomedical research organizations have unique
and evolving software needs due to their specific suites
of pre-existing infrastructure, distinctive organizational
processes, and involvement in rapidly changing areas of
science. A data integration platform like LabKey Server
must therefore be tailored to such an organization’s
needs before the system becomes useful. The effort to
successfully establish an installation of the platform
should not be underestimated.
Additional boundaries of the platform stem from its
scientific focus. The platform provides little direct sup-
port for managing the business side of scientific enter-
prises. It provides specimen request management and
generalized issue tracking, but it does not replace exist-
ing tools for such things as ordering reagents, tracking
inventory, managing freezer layouts and scheduling
work shifts. The platform does not aim to replace mass-
market collaboration software, so it does not provide
SharePoint-style document co-authoring.
LabKey Server’s facilities for tracking disease progres-
sion over time focus principally on associating data with
individuals (subjects, participants or animals) and time
points. These tools are less useful for experimental lab
studies that focus on replicates, such as experiments on
yeast biochemistry. Studies that require location as a key
identifier, such as geographic studies of disease spread,
would require support that is not yet built into the plat-
form. The system is not currently designed around the
Figure 18 Custom, per-participant views of data.P a r t i c i p a n t -
specific summary views show all data available for a particular
participant, typically along with visualizations. These views can be
customized using the graphical interface or through custom scripts.
This figure shows a custom view built on Atlas using LabKey Server’s
R interface and JavaScript client library. It is available only on Atlas.
Clinical data for the selected participant are displayed alongside a
graph that plots viral loads and CD4+ counts against the number of
days from enrolment in the study to specimen collection. Users can
toggle between different types of data (e.g., “Requested Specimens,”
“Binding Antibodies” or “Cytokines”) using tabs. Just as in the per-
participant views shown in Figure 10A and Figure 16, users can
employ the “Previous Participant” and “Next Participant” links to
progress to the same data summary for other participants in the
study. The participant identifier in this image is not real and the
physical information for the participant has been obscured.
Figure 19 Custom study summaries defined in an Atlas
module. LabKey Server modules can be used to encapsulate
scientifically interesting applications. Atlas’s vaccine study module
defines several interfaces that generate interactive summaries of
vaccine studies, including the interface displayed in this figure. This
module is tailored to Atlas-specific data, so it is not part of the
open source project. Generated summaries like the one shown in
this figure make it easier for scientists to swiftly, publicly share study
information and protocols after publishing associated research
papers. The Atlas web portal respects user permissions, so study
summaries display different amounts of information to different tiers
of users. Atlas login is not required to view public study data, so
you can explore the interfaces and data summaries defined in the
vaccine study module without acquiring Atlas credentials:
https://atlas.scharp.org/cpas/viscstudies/VISC/Completed%20CAVD%
20Studies/studydesigns.view.
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Page 19 of 23execution of clinical trials; nevertheless, organizations
such as HVTN still use it to share and adjudicate results.
At present, the study-based specimen tracking and
request system requires that uploaded specimen data
conform to a specific format based on the output of a
particular LIMS, LDMS [56]. Greater flexibility towards
specimen input formats would not be difficult to add.
The system already provides other tools for tracking
arbitrarily shaped specimen data, but these do not sup-
port requests.
LabKey Server provides features (such as role-based
security, authentication, audit logging and write-once rules
for assay data) that are designed to meet the requirements
of FDA Regulation 21 CFR Part 11. However, no installa-
tion of the platform has yet undergone full, formal evalua-
tion for compliance. Compliance can only be certified for
installations of software, not the software itself.
LabKey provides for data export in multiple formats,
but does not yet provide protocols for data transfer to
permanent, domain-specific archives, as do ISA and
SIMBioMS [11,9].
Next Steps for LabKey Server in Support of Atlas
A key future focus for Atlas will be the development of new
tools for interactive visualization and data exploration.
These tools will allow more efficient extraction of informa-
tion and insight from Atlas. Data exploration features will
include interactive graphics, new tabular displays tailored
to requests from investigators and tools for quickly per-
forming analysis of variance (ANOVA) calculations and
other statistical analyses. The data exploration tools will be
combined with improved data submission capabilities,
allowing investigators to swiftly and easily combine their
own data with data stored on Atlas. In addition, we expect
to simplify the application of existing ontologies to data
types, allowing richer integration of data across indepen-
dent datasets. We are also prototyping a distributed HIV
dataspace [77] that would provide a catalogue of data
stored in a variety of locations.
Additional areas of focus may include the development of
new custom assay tools (following the successful model of
the TZM-bl neutralizing antibody assay) and the enhance-
ment of full-text search. Integrating deeper knowledge of
biomedical concepts into full-text search would better
enable searches for scientifically relevant information.
Additional Next Steps for LabKey Server
Future areas of focus depend on the needs of users who
fund further development of the core platform.
Enhancements to the LabKey client libraries to aid
application development have been a particularly consis-
tent area of focus among user-funders. Support for
next-generation sequencing data and integration with
Galaxy [78] is currently funded and under development.
Adoption of the platform by consortia studying diseases
beyond HIV would require certain enhancements, such
as new custom data types, but the basic platform has
been designed for use by consortia studying any disease.
Conclusions
Sharing data, analysis tools and infrastructure can accel-
erate the efforts of large research consortia by enabling
new insights and enhancing efficiency. The Atlas instal-
lation of LabKey Server demonstrates the utility of the
LabKey platform for collaborative research. Like all Lab-
Key Server installations, Atlas supports secure, web-
based data sharing and collaboration from the earliest
stages of disease research; enables integration of diverse
and changing data types based on subject and/or visit
identifiers; allows easy customization of interfaces,
wizards, analyses, and visualizations; supports program-
matic automation and customization; supplies advanced
tools for data querying, search and analysis; provides
dynamic access to external databases; enables staging of
data based on quality control status; and provides speci-
men request management.
Real-world adoption of Atlas by members of the
Enterprise has helped the LabKey Server team refine the
features of the base platform to suit the needs of a wide
range of researchers. Functionality tailored to be useful
to a broad array of scientists has helped to catalyze
adoption of the platform beyond the Enterprise. Funding
agencies’ growing enthusiasm for collaboration among
disease researchers [3,79] suggests that the platform will
become increasingly useful to a wider circle of research-
ers focused on other diseases.
LabKey Server’s open source license means that other
research consortia can freely adapt the base platform to
their needs while contributing new features back to the
effort and improving the software for all users. The plat-
form’s track record of regular, stable releases and
ongoing maintenance provide a reassuring complement
to its open source availability.
Methods
This section covers the methods used for measuring
Atlas usage. Counts of active Atlas user accounts were
made on May 11, 2010, as were estimates of the number
of organizations and countries represented by these
counts. To estimate the number of organizations using
Atlas, we counted the distinct domains used by active
user email accounts. This count excluded obvious dupli-
cates (e.g., multiple email domains at the National Insti-
tute of Health) and obvious commercial, non-
organizational email accounts (e.g., Gmail, Yahoo and
others). The total count may be an overestimate because
there could have been further duplication, so it is useful
mostly as a benchmark.
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used, each user account was associated with a country
of origin based on the account’s country code top-level
domain. If the domain did not include a country code
(e.g., .com or .org domains), the domain was assigned to
the United States category. This practice made the
country count a conservative estimate.
Overall counts of assays uploaded to Atlas, customized
views, wiki pages and message board posts were made on
May 11, 2010 by querying the production server’sP o s t -
greSQL database. Counts of specimens were made on
May 17, 2010 on the staging server, whose content mir-
rors the production server with only a slight time lag.
NAb, Luminex and ELISpot assay runs were counted on
the staging server on January 10, 2011 for the purpose of
comparing adoption rates for these assay tools. Counts of
SCHARP-authored applications and tools on Atlas were
made on the production server in October 2009 and
included wiki-authored tools, file-based applications
(excluding static content) and full-fledged modules.
Traffic to the Atlas web site was measured through
Google Analytics. Tracking began in July 2008. Mea-
surements for the month of April 2010 were compared
to measurements in October 2009 to estimate current
trends in usage.
Availability and Requirements
LabKey Server Open Source and Compiled Binaries
T h eL a b K e yS e r v e ro p e ns o u r c es o f t w a r ei sf r e e l ya v a i l -
able for download at http://www.labkey.org under the
terms of the Apache License 2.0 [1]. This site also pro-
vides documentation, tutorials and demos for users and
developers, plus instructions for developers who wish to
contribute code to the project through the LabKey Sub-
version repository.
Compiled binaries for Windows, Unix, Linux or
Macintosh installation are available for free through
LabKey Software at http://www.labkey.com. A graphical
installer is available for computers running Windows
XP or later. It includes the LabKey web application; the
Apache Tomcat web server, v5.5.29; the Java Runtime
Environment, v1.6.0-22; the PostgreSQL database server,
v8.3.7; and additional third-party components.
￿ Project name: LabKey Server
￿ Project home page: http://www.labkey.org
￿ Operating system(s): Platform independent
￿ Programming languages: Java, JavaScript, R, SAS,
etc.
￿ Other requirements, as of LabKey v10.3: Apache
Tomcat (5.5.29 or 5.5.31); Java Runtime Environ-
ment 6; and either PostgreSQL (8.2, 8.3 or 9.0) or
Microsoft SQL Server (2005 or 2008). Check the
project site for latest requirements of the most
recent release.
￿ License: Apache License 2.0 [1]
Hardware Requirements
LabKey Server can run on any type of modern computer
hardware. Typically, the needs of the database are much
greater than the web server, so these may run on differ-
ent machines. Hardware requirements depend on the
load placed on the system. In general, a modern, server-
level system running Windows or a Unix-based operat-
ing system is sufficient for a modest deployment.
Access to the Atlas Database
Access to Atlas is available to participating members of
the research networks supported by SCHARP as part of
t h eE n t e r p r i s e( C A V D ,C H A V I ,M T N ,H V T Na n dV I S C
at present). To inquire about access, contact atlas@-
scharp.org. Published results and information about cer-
tain projects are available to the public without logon at
https://atlas.scharp.org. For example, all completed
CAVD studies are published on Atlas in the VISC folder.
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